137 related articles for article (PubMed ID: 16290986)
1. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina.
Segev A; Strauss BH; Witztum JL; Lau HK; Tsimikas S
Am Heart J; 2005 Nov; 150(5):1007-14. PubMed ID: 16290986
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
3. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
6. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
Remkes WS; Somi S; Roolvink V; Rasoul S; Ottervanger JP; Gosselink AT; Hoorntje JC; Dambrink JH; de Boer MJ; Suryapranata H; van 't Hof AW;
JACC Cardiovasc Interv; 2014 Jul; 7(7):751-8. PubMed ID: 25060017
[TBL] [Abstract][Full Text] [Related]
7. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
8. Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis.
Breuckmann F; Naber C; Beckert J; Schmermund A; Haude M; Baumgart D; Erbel R
Int J Cardiol; 2006 Mar; 108(1):20-5. PubMed ID: 16516694
[TBL] [Abstract][Full Text] [Related]
9. Using oxidized low-density lipoprotein autoantibodies to predict restenosis after balloon angioplasty in patients with acute myocardial infarction.
Huang CH; Chang CC; Huang CS; Kuo CL; Chen CP; Hsia CH; Chang YM; Chen HT; Feng CC; Lin LS; Yang PT; Tsai CD; Lin CS; Liu CS
PLoS One; 2013; 8(10):e74726. PubMed ID: 24098346
[TBL] [Abstract][Full Text] [Related]
10. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
[TBL] [Abstract][Full Text] [Related]
11. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
Saleh N; Tornvall P
Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
[TBL] [Abstract][Full Text] [Related]
12. Re-angioplasty of in-stent restenosis versus balloon restenoses--a matched pair comparison.
Wöhrle J; Kochs M; Vollmer C; Kestler HA; Hombach V; Höher M
Int J Cardiol; 2004 Feb; 93(2-3):257-62. PubMed ID: 14975556
[TBL] [Abstract][Full Text] [Related]
13. Association of leukocyte activation, but not the common cold, with restenosis after percutaneous coronary intervention in patients with angina pectoris.
Inami N; Nomura S; Kimura Y; Sutani Y; Yamada K; Nakamori H; Takahashi N; Tsuda N; Fukuhara S; Iwasaka T
Pathophysiol Haemost Thromb; 2005; 34(1):13-7. PubMed ID: 16293980
[TBL] [Abstract][Full Text] [Related]
14. L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty.
George J; Shmuel SB; Roth A; Herz I; Izraelov S; Deutsch V; Keren G; Miller H
Atherosclerosis; 2004 Jun; 174(2):323-7. PubMed ID: 15136062
[TBL] [Abstract][Full Text] [Related]
15. Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel.
Schühlen H; Kastrati A; Mehilli J; Hausleiter J; Dirschinger J; Dotzer F; Bollwein H; Schömig A
Am Heart J; 2006 Jun; 151(6):1248-54. PubMed ID: 16781230
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
Inami N; Nomura S; Manabe K; Kimura Y; Iwasaka T
Platelets; 2006 Dec; 17(8):565-70. PubMed ID: 17127484
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
[TBL] [Abstract][Full Text] [Related]
19. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.
Reynen K; Köckeritz U; Kropp J; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
Int J Cardiol; 2004 May; 95(1):29-34. PubMed ID: 15159034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
